Differential expression of E-cadherin gene in human neuroepithelial tumors

F.J.N. Motta, E.T. Valera, A.K.B. Lucio-Eterovic, R.G.P. Queiroz, L. Neder, C.A. Scrideli, H.R. Machado, C.G. Carlotti-Junior, S.K.N. Marie, L.G. Tone
Published: April 08, 2008
Genet. Mol. Res. 7 (2) : 295-304
DOI: https://doi.org/10.4238/vol7-2gmr424

Cite this Article:
F.J.N. Motta, E.T. Valera, A.K.B. Lucio-Eterovic, R.G.P. Queiroz, L. Neder, C.A. Scrideli, H.R. Machado, C.G. Carlotti-Junior, S.K.N. Marie, L.G. Tone (2008). Differential expression of E-cadherin gene in human neuroepithelial tumors. Genet. Mol. Res. 7(2): 295-304. https://doi.org/10.4238/vol7-2gmr424

About the Authors
F.J.N. Motta, E.T. Valera, A.K.B. Lucio-Eterovic, R.G.P. Queiroz, L. Neder, C.A. Scrideli, H.R. Machado, C.G. Carlotti-Junior, S.K.N. Marie, L.G. Tone

Corresponding author
F.J.N. Motta
E-mail: motta@ufpi.edu.br

ABSTRACT

Cadherins are cell-to-cell adhesion molecules that play an important role in the establishment of adherent-type junctions by mediating calcium-dependent cellular interactions. The CDH1 gene encodes the transmembrane glycoprotein E-cadherin which is important in maintaining homophilic cell-cell adhesion in epithelial tissues. E-cadherin interacts with catenin proteins to maintain tissue architecture. Structural defects or loss of expression of E-cadherin have been reported as a common feature in several human cancer types. This study aimed to evaluate the expression of E-cadherin and their correlation with clinical features in microdissected brain tumor samples from 81 patients, divided into 62 astrocytic tumors grades I to IV and 19 medulloblastomas, and from 5 white matter non-neoplasic brain tissue samples. E-cadherin (CDH1) gene expression was analyzed by quantitative real-time polymerase chain reaction. Mann-Whitney, Kruskal-Wallis, Kaplan-Meir, and log-rank tests were performed for statistical analyses. We observed a decrease in expression among pathological grades of neuroepithelial tumors. Non-neoplasic brain tissue showed a higher expression level of CDH1 gene than did neuroepithelial tumors. Expression of E-cadherin gene was higher in astrocytic than embryonal tumors (P = 0.0168). Low-grade malignancy astrocytomas (grades I-II) showed higher CDH1 expression than did high-grade malignancy astrocytomas (grades III-IV) and medulloblastomas (P 0.0001). Non-neoplasic brain tissue showed a higher expression level of CDH1 gene than grade I malignancy astrocytomas, considered as benign tumors (P = 0.0473). These results suggest that a decrease in E-cadherin gene expression level in high-grade neuroepithelial tumors may be a hallmark of malignancy in dedifferentiated tumors and that it may be possibly correlated with their progression and dissemination.

Key words: Cancer, Neuroepithelial tumors, CDH1 expression, Real-time polymerase chain reaction.

 

Back To Top